ILB®
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ILB®, covering 2025-06-26 to 2025-06-26. Get the full timeline:
Most recent: Clinical Trial Update: A Safety and Tolerability Study of ILB® in Patients With Amyotrophic Lateral Sclerosis (ALS) [Phase 2]